振东制药：控股股东质押0.73%公司股份

Core Viewpoint - The announcement reveals that the controlling shareholder of Zhendong Pharmaceutical, Zhendong Group, has pledged 7.32 million shares of the company, which accounts for 2.42% of its holdings and 0.73% of the total share capital of the company [1] Summary by Relevant Categories Share Pledge Details - The pledge started on July 17, 2025, and the purpose of the pledge is for the group's own production and operation [1] - After this pledge, Zhendong Group has cumulatively pledged 200 million shares, representing 66.08% of its holdings and 19.86% of the total share capital of the company [1]